Literature DB >> 29022837

Critical Parameters for Particle-Based Pulmonary Delivery of Chemotherapeutics.

Ali Dabbagh1, Noor Hayaty Abu Kasim1, Chai Hong Yeong2, Tin Wui Wong3, Noorsaadah Abdul Rahman4,5.   

Abstract

Targeted delivery of chemotherapeutics through the respiratory system is a potential approach to improve drug accumulation in the lung tumor, while decreasing their negative side effects. However, elimination by the pulmonary clearance mechanisms, including the mucociliary transport system, and ingestion by the alveolar macrophages, rapid absorption into the blood, enzymatic degradation, and low control over the deposition rate and location remain the main complications for achieving an effective pulmonary drug delivery. Therefore, particle-based delivery systems have emerged to minimize pulmonary clearance mechanisms, enhance drug therapeutic efficacy, and control the release behavior. A successful implementation of a particle-based delivery system requires understanding the influential parameters in terms of drug carrier, inhalation technology, and health status of the patient's respiratory system. This review aims at investigating the parameters that significantly drive the clinical outcomes of various particle-based pulmonary delivery systems. This should aid clinicians in appropriate selection of a delivery system according to their clinical setting. It will also guide researchers in addressing the remaining challenges that need to be overcome to enhance the efficiency of current pulmonary delivery systems for aerosols.

Entities:  

Keywords:  chemotherapeutics; clearance; particles; pulmonary drug delivery systems

Mesh:

Substances:

Year:  2017        PMID: 29022837     DOI: 10.1089/jamp.2017.1382

Source DB:  PubMed          Journal:  J Aerosol Med Pulm Drug Deliv        ISSN: 1941-2711            Impact factor:   2.849


  8 in total

Review 1.  Novel Approaches for the Treatment of Pulmonary Tuberculosis.

Authors:  Zhi Ming Tan; Gui Ping Lai; Manisha Pandey; Teerapol Srichana; Mallikarjuna Rao Pichika; Bapi Gorain; Subrat Kumar Bhattamishra; Hira Choudhury
Journal:  Pharmaceutics       Date:  2020-12-10       Impact factor: 6.321

Review 2.  Nanoparticles-assisted delivery of antiviral-siRNA as inhalable treatment for human respiratory viruses: A candidate approach against SARS-COV-2.

Authors:  Ata Ullah; Javaria Qazi; Lutfur Rahman; Antonios G Kanaras; Waheed S Khan; Irshad Hussain; Asma Rehman
Journal:  Nano Sel       Date:  2020-10-12

3.  Aerosolized nanoliposomal carrier of remdesivir: an effective alternative for COVID-19 treatment in vitro.

Authors:  Richa Vartak; Suyash M Patil; Aishwarya Saraswat; Manali Patki; Nitesh K Kunda; Ketan Patel
Journal:  Nanomedicine (Lond)       Date:  2021-05-13       Impact factor: 5.307

4.  Afatinib-loaded inhalable PLGA nanoparticles for localized therapy of non-small cell lung cancer (NSCLC)-development and in-vitro efficacy.

Authors:  Rasha S Elbatanony; Vineela Parvathaneni; Nishant S Kulkarni; Snehal K Shukla; Gautam Chauhan; Nitesh K Kunda; Vivek Gupta
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 5.671

Review 5.  siRNA Conjugated Nanoparticles-A Next Generation Strategy to Treat Lung Cancer.

Authors:  Rasha Itani; Achraf Al Faraj
Journal:  Int J Mol Sci       Date:  2019-12-03       Impact factor: 5.923

Review 6.  Nanobased Platforms for Diagnosis and Treatment of COVID-19: From Benchtop to Bedside.

Authors:  Elham Bidram; Yasaman Esmaeili; Abbas Amini; Rossella Sartorius; Franklin R Tay; Laleh Shariati; Pooyan Makvandi
Journal:  ACS Biomater Sci Eng       Date:  2021-05-12

Review 7.  Nanoparticle Delivery Systems with Cell-Specific Targeting for Pulmonary Diseases.

Authors:  Zicheng Deng; Gregory T Kalin; Donglu Shi; Vladimir V Kalinichenko
Journal:  Am J Respir Cell Mol Biol       Date:  2021-03       Impact factor: 6.914

Review 8.  A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers.

Authors:  Ruhisy Mohd Rasul; M Tamilarasi Muniandy; Zabliza Zakaria; Kifayatullah Shah; Chin Fei Chee; Ali Dabbagh; Noorsaadah Abd Rahman; Tin Wui Wong
Journal:  Carbohydr Polym       Date:  2020-08-18       Impact factor: 9.381

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.